Company: KEQU
Filing Date: 2025-07-02
Form Type: 10-K
Source: 0000055529-25-000026
Chunk: 281

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-07-02
Form: 10-K
Item: Item 8
Chunk 281
---
,000 shares;Issued— 2,941 shares (2025); 2,909 shares (2024)Outstanding— 2,839 shares (2025); 2,839 shares (2024)7,353 7,273 Additional paid-in capital5,635 5,406 Retained earnings58,919 47,514 Accumulated other comprehensive loss(3,803)(3,382)Common stock in treasury, at cost: 103 shares (2025); 70 shares (2024)(3,647)(2,051)Total Kewaunee Scientific Corporation Stockholders' Equity64,457 54,760 Non-controlling interest1,788 1,449 Total Stockholders' Equity66,245 56,209 Total Liabilities and Stockholders' Equity$194,654 $134,766 

The accompanying Notes are an integral part of these Consolidated Financial Statements.

27

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years Ended April 30Kewaunee Scientific Corporation$ in thousands20252024Cash Flows from Operating ActivitiesNet earnings$11,583 $19,057 Adjustments to reconcile net earnings to net cash used by operating activities:Depreciation and amortization4,759 3,125 Provision for credit losses68 276 Stock based compensation expense1,441 1,028 Provision for deferred income taxes(2,202)(7,127)Accrued payment in kind ("PIK") interest935 — Amortization of deferred financing costs218 — Change in assets and liabilities (net of effect of acquisition):Receivables(6,738)741 Inventories3,351 1,210 Accounts payable and other accrued expenses583 691 Deferred revenue765 277 Other, net20 286 Net cash provided by operating activities14,783 19,564 Cash Flows from Investing ActivitiesCapital expenditures(2,166)(4,373)Purchase of business, net of cash acquired(28,735)— Net cash used in investing activities(30,901)(4,373)Cash Flows from Financing ActivitiesDividends paid to non-controlling interest in subsidiaries(261)— Proceeds from term loan15,000 — Repayments on term loan(1,250)— Proceeds from short-term borrowings